Live Breaking News & Updates on Nonalcoholic Steato Hepatitis
Stay updated with breaking news from Nonalcoholic steato hepatitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lupin and Zydus Lifesciences entered into a licensing and supply agreement to co-market Saroglitazar Mg, an innovative drug approved by India s DCGI for treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS. ....